Post-approval studies (Phase 4)Study completedNCT03780361
What this trial is testing
Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT)
Who this might be right for
Diabetic Macular Edema
Hyewon Chung 23